Please login to the form below

Not currently logged in
Email:
Password:

Sanofi’s US pharma head joins Synta as CEO

Anne Whitaker also has experience at GSK
synta-anne-whitaker

Synta Pharmaceuticals has named the former head of Sanofi's pharma operations in the US and Canada as its new CEO.

Anne Whitaker served as president, North America pharmaceuticals, at Sanofi since September 2011 overseeing all pharma and consumer healthcare operations within the region. She also served as a member of Sanofi's global leadership team, global commercial operations committee and US regional management committee.

She now leads an emerging US-based biopharma focused on the development of small molecule drugs to treat patients with severe medical conditions, including cancer and chronic inflammatory diseases.

“Synta presents an exciting opportunity defined by a late stage product, ganetespib, that has shown promising activity in multiple indications and a pre-clinical programme, HDC, that has significant potential to generate new drug candidates,” said Whitaker.

Prior to joining Sanofi in 2011, Whitaker spent nearly two decades at GlaxoSmithKline (GSK), progressing through the ranks to eventually hold a senior VP role. She began her career at Delta Communications before joining the Upjohn Company in 1991 as a metabolic disease specialist.

14th August 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics